Abacavir sulfate -: Anti-HIV -: Ziagen® -: reverse transcriptase inhibitor

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 11期
关键词：
TAP; takeda;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1094 / 1094
页数：1
相关论文
共 50 条
  • [21] Potent NLRP3 Inflammasome Activation by the HIV Reverse Transcriptase Inhibitor Abacavir
    Toksoy, Atiye
    Sennefelder, Helga
    Adam, Christian
    Hofmann, Sonja
    Trautmann, Axel
    Goebeler, Matthias
    Schmidt, Marc
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (07) : 2805 - 2814
  • [22] Development of a vaginal delivery film containing EFdA, a novel anti-HIV nucleoside reverse transcriptase inhibitor
    Zhang, Wei
    Parniak, Michael A.
    Sarafianos, Stefan G.
    Cost, Marilyn R.
    Rohan, Lisa C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 461 (1-2) : 203 - 213
  • [23] Identification of anti-HIV and anti-Reverse Transcriptase activity from Tetracera scandens
    Kwon, Hyeok Sang
    Park, Jung Ae
    Kim, Joo-Hwan
    You, Ji Chang
    BMB REPORTS, 2012, 45 (03) : 165 - 170
  • [24] Potent NLRP3 inflammasome activation by the HIV reverse-transcriptase inhibitor abacavir
    Toksoy, A.
    Sennefelder, H.
    Adam, C.
    Hofmann, S.
    Trautmann, A.
    Goebeler, M.
    Schmidt, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 89 - 89
  • [25] Safety analysis of Ziagen® (abacavir sulfate) in postmarketing surveillance in Japan
    Kurita, Tomoko
    Kitaichi, Tomomi
    Nagao, Takako
    Miura, Toshiyuki
    Kitazono, Yoshifumi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (04) : 361 - 371
  • [26] Action of Anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease inhibitors
    Imamichi, T
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (32) : 4039 - 4053
  • [27] Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptase
    Kammarabutr, Jirayu
    Mahalapbutr, Panupong
    Okumura, Hisashi
    Wolschann, Peter
    Rungrotmongkol, Thanyada
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (07): : 2502 - 2511
  • [28] Synthesis of prodrug-type anti-HIV agents conjugating a REVERSE transcriptase inhibitor to a HIV-1 integrase inhibitor by a spontaneously cleavable linker
    Fossey, Christine
    Vu, Anh-Hoang
    Vidu, Anamaria
    Zarafu, Irina
    Laduree, Daniel
    Schmidt, Sylvie
    Laumond, Geraldine
    Aubertin, Anne-Marie
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2007, 22 (05) : 591 - 607
  • [29] GW-420867X -: GW-867 -: HBY-1293 -: Anti-HIV reverse transcriptase inhibitor
    不详
    DRUGS OF THE FUTURE, 2001, 26 (01) : 79 - 79
  • [30] Characterization of Cyclodextrin Inclusion Complexes of the Anti-HIV Non-Nucleoside Reverse Transcriptase Inhibitor UC781
    Yang, Haitao
    Parniak, Michael A.
    Isaacs, Charles E.
    Hillier, Sharon L.
    Rohan, Lisa C.
    AAPS JOURNAL, 2008, 10 (04): : 606 - 613
12345